DEVELOPMENT AND VALIDATION OF GENERALIZABLE INTERPRETABLE AI BIOMARKERS TO PREDICT CLINICAL OUTCOMES IN BCG-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER

被引：0
|
作者：
Lotan, Yair
Shah, Jay B.
Krishna, Viswesh
Launer, Bryn
Krishna, Vrishab
Shingi, Siddhant
Gordetsky, Jennifer
Gerald, Thomas
Shkolyar, Eugene
Hayne, Dickon
Redfern, Andrew
Spalding, Lisa
Stewart, Courtney
Narayanan, Vikram
Patil, Dattatreya
Packiam, Vignesh T.
Rajan, Anand
O'Donnell, Michael A.
Baekelandt, Loic
Fernandez, Mario I.
Schultz, Marcela
Hensley, Patrick J.
Allison, Derek B.
Taylor, John A.
Hamza, Ameer
Nimgaonkar, Vivek
Tiu, Ekin
Vaickus, Louis J.
Sonawane, Snehal
Miller, Daniel L.
Vrabac, Damir
Abuzeid, Waleed M.
Joshi, Anirudh
Chang, Sam S.
Williams, Stephen B.
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD27-12
引用
收藏
页码：E555 / E556
页数：2
相关论文
共 50 条
  • [1] CONTEMPORARY OUTCOMES OF NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS TREATED WITH INDUCTION BCG
    Matulay, Justin
    Li, Roger
    Navai, Neema
    Nagaraju, Supriya
    Narayan, Vikram
    Lim, Amy
    Grossman, H. Barton
    Czerniak, Bogdan
    Guo, Charles
    Dinney, Colin
    Kamat, Ashish
    JOURNAL OF UROLOGY, 2019, 201 (04): : E618 - E618
  • [2] TREATMENT PATTERN, MORTALITY AND COSTS AMONG BCG-TREATED NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) PATIENTS IN GERMANY
    Quignot, N.
    Doobaree, I
    Jiang, H.
    Lehmann, J.
    Ghatnekar, O.
    VALUE IN HEALTH, 2022, 25 (01) : S251 - S251
  • [3] CORRELATION BETWEEN BMI AND OUTCOMES IN PATIENTS TREATED WITH BCG IMMUNOTHERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Brooks, Nathan
    Matulay, Justin
    Xiao, Lianchun
    Li, Roger
    Kokorovic, Andrea
    Grossman, H. Barton
    Shen, Yu
    Gao, Jianjun
    Navai, Neema
    Dinney, Colin
    Kamat, Ashish
    JOURNAL OF UROLOGY, 2020, 203 : E1075 - E1075
  • [4] Development and external validation of a model to predict recurrence in patients with non-muscle invasive bladder cancer
    Tang, Jiajia
    Fan, Longmei
    Huang, Tianyu
    Yang, Rongrong
    Yang, Xinqi
    Liao, Yuanjian
    Zuo, Mingshun
    Zhang, Neng
    Zhang, Jiangrong
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [5] HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER WITH VARIANT HISTOLOGY OR OTHER SUBTYPES NOT A PREDICTOR FOR PROGRESSION IN BCG-TREATED PATIENTS
    Craig, Calkins Daniel
    Facundo, Davaro
    Chris, Guske
    Richard, Sirard, III
    Roger, Li
    Scott, Gilbert
    Wade, Sexton
    Philippe E, Spiess
    Michael, Poch
    Alice, Yu
    Logan, Zemp
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S52 - S52
  • [6] Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis
    Quignot, Nadia
    Jiang, Heng
    Doobaree, Indraraj Umesh
    Lehmann, Jan
    Ghatnekar, Ola
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2023, 15 : 227 - 237
  • [7] Long-term outcomes among BCG-treated high-risk non-muscle invasive bladder cancer patients in an equal access setting.
    Williams, Stephen B.
    Howard, Lauren
    Foster, Meagan
    Klaassen, Zachary William Abraham
    Sieluk, Jan
    Li, Haojie
    Imai, Kentaro
    Sbar, Eric
    De Hoedt, Amanda M.
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Long-Term Outcomes and Costs Among BCG-treated High-Risk Non-Muscle Invasive Bladder Cancer Patients in an Equal Access Setting
    Williams, S. B.
    Howard, L. E.
    Foster, M. L.
    Klaassen, Z.
    Li, H.
    Sieluk, J.
    Imai, K.
    Sbar, E., I
    De Hoedt, A. M.
    Freedland, S. J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 902 - 902
  • [9] Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer
    Catto, J. W. F.
    Tran, B.
    Roupret, M.
    Gschwend, J. E.
    Loriot, Y.
    Nishiyama, H.
    Redorta, J. P.
    Daneshmand, S.
    Hussain, S. A.
    Cutuli, H. J.
    Procopio, G.
    Guadalupi, V.
    Vasdev, N.
    Naini, V.
    Crow, L.
    Triantos, S.
    Baig, M.
    Steinberg, G.
    ANNALS OF ONCOLOGY, 2024, 35 (01) : 98 - 106
  • [10] NON-MUSCLE INVASIVE BLADDER CANCER RESISTANT TO BCG
    Turker, Polat
    Turkeri, Levent
    ARCHIVOS ESPANOLES DE UROLOGIA, 2013, 66 (09): : 833 - 840
12345